Halaman 4 - Imunohistokimia Dokter Terbaik - TOP-92 dokter

Dr. Boaz Liberman, MD, is an orthopedic oncologist and sarcoma surgeon for adults and children. He directs the Orthopedic Oncology Unit and serves as Vice Head of Orthopedic Surgery at Sheba Medical Center. His focus is limb-sparing cancer surgery with functional reconstruction. He performs complex joint reconstruction, revision arthroplasty, MRgFUS, and reconstruction after bone metastases.

Education and training: MD, Tel Aviv University. Orthopedic surgery residency, Sheba Medical Center. Fellowships in Adult Reconstruction at Mount Sinai Hospital, Toronto, and in Orthopedic Oncology at Mount Sinai Hospital and Princess Margaret Cancer Centre. He is board-certified in Orthopedic Surgery and in Orthopedic Oncology Surgery. He is a Clinical Instructor at Tel Aviv University. Memberships include the Israel Medical Association, Israel Orthopedic Association, AATB, and EATB. He also serves on national advisory committees. His research covers bone and soft tissue sarcomas, serum markers, imaging-guided therapies, MRI arthrography, and the biomechanics of bone treated with MRgFUS.

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Dengan 20 tahun praktik, dokter ini mengkhususkan diri dalam hematologi dan onkologi pediatrik, dengan fokus pada penyakit kanker darah yang langka. Dia telah melakukan lebih dari 3.500 transplantasi sumsum tulang, mendapatkan reputasi di antara pasien sebagai orang yang "mentransplantasikan kehidupan."

Keahlian dan dedikasinya telah diakui oleh Forbes, yang menamainya sebagai salah satu dokter terbaik pada tahun 2018.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Dokter lulus dari Sekolah Kedokteran Hacettepe pada tahun 1985 dan menjadi Spesialis Penyakit Dalam di Universitas Ege pada tahun 1990. Untuk memperdalam keahliannya, dokter tersebut mengambil spesialisasi dalam hematologi dan menyelesaikan gelar Ph.D. di Sekolah Kedokteran Mie Jepang pada tahun 1995. Pada tahun 1997, dokter tersebut telah maju menjadi Asisten Profesor dan kemudian Profesor Hematologi di Universitas Ege. Pada tahun 2003, dokter tersebut melanjutkan sebagai Profesor Hematologi di Universitas Teknik Karadeniz. Dengan lebih dari 65 artikel ilmiah, 112 makalah pertemuan, dan 34 presentasi konferensi, dokter tersebut diakui atas kontribusinya dalam hematologi dan transplantasi sumsum tulang.<\/p>

Education

Istanbul University Cerrahpaşa Faculty of Medicine, 2002
Istanbul Fatih Sultan Mehmet Training and Research Hospital, Internal Medicine, 2010
Istanbul University Oncology Institute (Çapa), Medical Oncology, 2015
Medipol University Faculty of Medicine, Phytotherapy Education, 2018
University of Health Sciences, Vocational School of Health, Molecular Oncology, PhD Program, PhD, 2023

Experience

University Hospital, Newark, New Jersey, USA, Observer (2003-2004)
Siirt State Hospital, Internal Medicine (2010-2011)
Siirt State Hospital, Medical Oncology (2015)
Bakırköy Dr. Sadi Konuk Training and Research Hospital, Medical Oncology (2015-2018)
Istanbul University, Istanbul Faculty of Medicine, Department of Internal Medicine, Medical Oncology, (Professor Doctor) (2018-Present)
Forensic Medicine 3. Specialization Board, Medical Oncology, Full Member (2019-Present)
Liv Hospital, Ulus, Park-time, Medical Oncology (2020-2022)
Şişli Kolan International Hospital, Park-time, Medical Oncology (2022-2023)

Medical Intrests

• Gastrointestinal System Tumours (Esophagus - Stomach and Large Bowel Cancer)
• Hepatobiliary System Tumours (Liver-Biliary Tract and Pancreatic Cancer)
• Breast Cancer
• Lung Cancer
• Genitourinary Cancers
• Immunotherapies and Target Therapies
• Molecular Oncology
• Immunotherapies
• Target Treatments
•  

Awards

2010-YDUS (Subspecialty Examination) 14th place in Turkey
2014- Oncology Institute Days Best Poster Award
2015- Turkish Medical Oncology Society Board Exam Qualification
2015- ESMO (European Society for Medical Oncology) Board Exam Qualification

Education

• Faculty of Medicine: Trakya University, 1982-1988
• Radiation Oncology Residency: Şişli Etfal Training and Research Hospital, 1994-1998
• Radiation Oncology Residency: Princess Margaret Hospital Toronto, 1996
• Phytotherapy Master's Degree: Istanbul University Faculty of Pharmacy, 2017-2018

Experience

• Professor, Head of Department: Health Sciences University Bursa Faculty of Medicine, Department of Radiation Oncology, 2021-2024
• Professor, Head of Department: Health Sciences University Izmir Faculty of Medicine, Department of Radiation Oncology, 2021-2024
• Professor: Department of Radiation Oncology, Health Sciences University Istanbul Hamidiye Faculty of Medicine, 2021-2024
• Lecturer Gelisim University SMYO, 2013-2020

Medical Interests

• Breast Cancer / Intraoperative Radiotherapy
• Gynaecological Cancers / Brachytherapy Applications
• Gastrointestinal System Tumours
• Prostate Cancer / Hydrogel Space Oar Certificate and Application
• Lung Cancers
• Brain Tumours
• Head and Neck Cancers

Education

• Undergraduate: Istanbul Faculty of Medicine, Istanbul University, 2007
• MSc (Internal Medicine Department): Marmara University Faculty of Medicine, 2012
• PhD (Hematology Clinic): Istanbul Training and Research Hospital, 2018
• Associate Professor (Hematology Clinic): Prof.Dr.Cemil Tascioglu Training and Research Hospital, 2019

Prof. Dr. Rafet Eren graduated from Istanbul Faculty of Medicine in 2007. He completed his Internal Medicine specialty training at Marmara University Faculty of Medicine in 2012. In 2018, he became a Hematology subspecialist at Istanbul Training and Research Hospital. In 2019, he was awarded the title of Associate Professor in the field of Hematology. Afterwards, he worked as a faculty member at Başakşehir Çam and Sakura City Hospital, Bozyaka Training and Research Hospital and Istinye University (Istinye University Bahçeşehir and Liv Hospital Vadistanbul) and is currently working at Biruni University Hospital. Dr. Rafet Eren is a member of Turkish Society of Hematology, Hematology Specialty Society and European Society of Hematology and speaks English fluently. He has around 50 publications in national and international refereed journals.

Scientific Memberships

• Turkish Hematology Association
• Hematology Specialty Society
• Turkish Internal Medicine Specialty Society
• European Society of Hematology
•  

Awards 

• Young Researcher Award (42nd National Hematology Congress), 2016
• Special Jury Paper Award (3rd Hematologic Oncology Congress), 2015
• Paper 3rd Prize (2nd Hematologic Oncology and Bone Marrow Transplantation Symposium), 2016

Dr. Hilmi Apak is a respected pediatric hematology-oncology specialist with more than 21 years of experience. He is trained in pediatric oncology. Dr. Apak has led advanced treatments, including bone marrow transplantation, leukemia chemotherapy, and CAR T-cell therapy.

He has published 75 international medical articles, showing his strong contribution to pediatric oncology research. Dr. Apak has worked as assistant editor for the Turkish Pediatrics Archives Periodical. He has also held important academic and leadership positions, such as Head of Pediatric Hematology-Oncology at Istanbul University-Cerrahpaşa.

Dokter lulus dari Fakultas Kedokteran Universitas Ankara pada tahun 1992 dan menjadi Spesialis Kedokteran di Fakultas Kedokteran Universitas Uludağ, Departemen Penyakit Anak. Pada tahun 2002, dokter menjabat sebagai Asisten Profesor di bidang Hematologi Pediatrik di institusi yang sama.<\/p>

Dokter ini berspesialisasi dalam diagnosis dan pengobatan kanker anak, leukemia (limfoma), penyakit perdarahan anak, oklusi vaskular, pengobatan anemia, dan kekurangan zat besi dan vitamin.<\/p>

Dengan latar belakang akademis yang kuat, dokter ini telah menerbitkan 15 artikel di jurnal internasional yang ditinjau sejawat, mempresentasikan 9 teks lengkap di pertemuan ilmiah internasional, menulis 3 buku atau bab buku, dan menerbitkan 8 artikel di jurnal lokal yang ditinjau sejawat.<\/p>

Dokter menyelesaikan pelatihan spesialisasi dalam Onkologi Radiasi di Fakultas Kedokteran Universitas Marmara dari tahun 2012 hingga 2016. Sebelumnya, dokter menyelesaikan gelar sarjana dalam bidang Kedokteran, yang diajarkan dalam bahasa Inggris, di institusi yang sama dari tahun 2004 hingga 2011. Dokter memiliki dasar yang kuat dalam pendidikan kedokteran, dimulai dengan pendidikan sekolah menengah di Sekolah Nomor Enam Belas Shirvan di Azerbaijan dari tahun 1998 hingga 2004.<\/p>

Dr. Itir Sirinoglu Temiz is a Professor of Hematology. She specializes in lymphoma, acute and chronic leukemias, multiple myeloma, thrombocytopenias, thrombosis, anemia, and bone marrow failure. She graduated with honors from Istanbul University Cerrahpaşa Faculty of Medicine. She completed her hematology training at Dr. Abdurrahman Yurtarslan Oncology Education and Research Hospital.

Dr. Sirinoglu Temiz has held key academic and administrative positions. She served as Head of Internal Medicine at IAU Faculty of Medicine. She was also Education and Administrative Manager at SBÜ Bakırköy Dr. Sadi Konuk EAH Hematology Clinic. She has broad experience in adult hematology, stem cell transplantation, and therapeutic apheresis. She currently practices at Liv Hospital.

Dokter adalah spesialis berpengalaman dalam onkologi hematologi anak dan seorang ahli bedah saraf pediatrik terkemuka di Spanyol. Dengan pengalaman praktis lebih dari 30 tahun, dokter memimpin Unit Hematologi & Onkologi Pediatrik di HM Hospitales, berfokus pada penyakit hematologi dan kanker yang parah pada anak-anak dan remaja.<\/p>

Dokter berspesialisasi dalam diagnosis dan pengobatan gangguan hematologi dan kanker, terutama dalam sistem eritrosit, mieloid, dan limfoid. Dokter berperan sebagai konsultan WHO dan UNESCO serta terlibat dalam kegiatan pengajaran dan penelitian.<\/p>

Kredensial pendidikan termasuk gelar dari Universidad Complutense de Madrid, University of Barcelona, dan University of Maryland.<\/p>

Dokter menyelesaikan MD dalam Penyakit Dalam di Shyam Shah Medical College dan menjalani Residensi Senior di departemen yang sama. Setelah itu, dokter menjabat sebagai Registrar dalam Onkologi Medis di Rumah Sakit Kanker Jawaharlal Nehru. Dokter menyelesaikan pelatihan DNB dalam Onkologi Medis di Rumah Sakit Indraprastha Apollo.<\/p>

Selama Residensi Senior, dokter memberikan kuliah di Sekolah Musim Dingin Internasional Onkologi di AIIMS dan mempresentasikan penelitian tentang Kanker Lambung di Simposium Kanker Gastrointestinal oleh American Society of Clinical Oncology. Dokter mengkhususkan diri dalam dasar molekuler kanker dan terapi yang ditargetkan.<\/p>

Dokter menerima pelatihan Onkologi Bedah di Tata Memorial Hospital, Mumbai, dan menyelesaikan MRCS di Royal College of Surgeons, Edinburgh. Memulai praktik pada tahun 2000, dokter mendirikan Curie Manavata Cancer Centre pada tahun 2007. Dengan 19 tahun pengalaman, dokter telah melakukan lebih dari 50.000 operasi kanker dan berpartisipasi dalam lebih dari 200 uji klinis. Dokter adalah penulis yang telah diterbitkan dengan banyak publikasi internasional dan nasional. Mengkhususkan diri dalam Onkologi Bedah Payudara dan Toraks, dokter adalah profesor untuk DNB Superspecialty Surgical Oncology dan Breast Surgery di MUHS.<\/p>

Dokter menyelesaikan MBBS dari MIMER, Pune, dan MS dari GMC Panaji. Pelatihan lanjutan termasuk beasiswa dua tahun dalam Onkologi Bedah di Tata Medical Centre, Kolkata, dengan fokus pada Kanker Gastrointestinal. Di Tata Medical Center, dokter bertugas sebagai Peneliti Utama Bersama dalam beberapa proyek penelitian asli. Setelah itu, dokter bekerja sebagai Asisten Profesor di Institut Kanker Negara dan Rumah Sakit Kanker Pemerintah, Aurangabad. Dengan pengalaman lebih dari 10 tahun, dokter telah berhasil melakukan lebih dari 10.000 operasi besar dan telah menerbitkan beberapa makalah Nasional dan Internasional. Mengkhususkan diri dalam Bedah Kanker Minimal Invasif.<\/p>

Dokter lulus dari Fakultas Kedokteran Universitas Uludağ dengan Diploma Kedokteran pada tahun 1983 dan menyelesaikan residensi dalam Onkologi Radiasi di Pusat Onkologi & Kedokteran Nuklir di Istanbul pada tahun 1990. Beasiswa pascadoktoral dalam Termoradioterapi diselesaikan di Universitas Thomas Jefferson dari tahun 1990 hingga 1994. Dokter menjabat sebagai Profesor dan Ketua Departemen Onkologi Radiasi di Fakultas Kedokteran Universitas Uludağ dari tahun 1994 hingga 2005 dan menjadi Koordinator Akreditasi Fakultas dari tahun 2001 hingga 2004.<\/p>

Dari tahun 2004 hingga 2017, dokter menjadi Profesor dan Direktur Departemen Onkologi Radiasi di Pusat Medis Anadolu, juga menjabat sebagai Koordinator Ilmu Onkologi dari tahun 2011 hingga 2017. Saat ini, dokter adalah Direktur Ilmu Onkologi di Rumah Sakit Medicana Bursa, posisi yang dipegang sejak tahun 2018.<\/p>

Prof. Dr. Osman İLHAN graduated from Ankara University Faculty of Medicine in 1978. After completing his internal medicine residency at the same faculty in 1982, he served as a senior resident at the GATA Hematology Clinic during his military service. After completing his mandatory service at SSK Ulus Hospital, he returned to Ankara University Faculty of Medicine for a subspecialty. In 1990, he became an associate professor of hematology. He worked in Genoa, Italy to increase his knowledge and experience in leukemia. He was part of the team that performed the first bone marrow stem cell transplant in Turkey. In 1996, he went to the MD Anderson Cancer Center in the USA to work on "Stem Cell Mobilization, Cryopreservation, and Transplantation." In 1996, he became a professor of hematology. In 1999, he was elected as the regional president of ESFH (European Society for Hemapheresis). Dr. İlhan, who was the founder and president of the Hemapheresis Society in 2000, joined the World Apheresis Association (WAA) in 2001. He became the President of the Turkish Hematology Association in October 2001. Dr. İlhan, who is an active member of the European Hematology Association (EHA), was a member of the accreditation committee (ECAH) for education. He played a role in the accreditation of Turkish hematologists in CME credits by participating in the accreditation of congresses and courses held in Turkey as a Provider Status. He served as the founding president of the Cellular Therapy and Regenerative Medicine Association established in 2008. He became the founding president of the Geriatric Hematology Association in 2011. He is the Honorary President of the World Apheresis Congress (WAA) held in 2012. Dr. İlhan, who previously served on drug licensing and ethics committees at the Ministry of Health, has also served as the Chairman of the Photopheresis-Apheresis Commission and the Scientific Committee for Bone Marrow Transplantation, as well as the Chairman of the National Organ Tissue Cell Coordination Board, the Scientific Board of Cord Blood, and the Stem Cell Research Board. He is the founding president of the STEM CELL FOUNDATION and has played an important role in the establishment of TURKOK (Turkish Stem Cell Donor Bank). Dr. İlhan has over 300 publications in journals registered in PubMed and more than 5000 citations. He holds the Platinum CME certificate from the European Hematology Association. He owns four brands/patents named “Kökten Çözüm (Deep Solution), Telehematoloji (Telehematology), Hemaferez (Hemapheresis), Kanser Kök Hücresi (Cancer Stem Cell)”. He is currently the President of the Ankara Medical Association. Prof. Dr. Osman İlhan, who served at Ankara University Faculty of Medicine for 50 years, began working at Özel Koru Ankara Hospital as of January 1, 2023.

His medical interests include:

Hematopoietic Stem Cell Transplantation (Autologous, Allogeneic)

Acute Leukemia

Chronic Leukemia Treatments

Hodgkin Lymphoma

Non-Hodgkin Lymphoma Treatments

Multiple Myeloma Treatments, MDS

Aplastic Anemia

ITP

TTP Treatments

Hypercoagulability

Hereditary Thrombophilia Treatments

Therapeutic Apheresis

Photopheresis

Geriatric Hematology Diseases.